BRLF1 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Product Specifications
Background
Immediate-early transcription factor that controls the initiation of viral lytic gene expression and lytic reactivation from latency. Triggers lytic replication, and initiates a cellular senescence program in epithelial cells. Upregulates human DCR3/TNFRSF6B by directly binding to its receptor.
Synonyms
Human herpesvirus 4 type 2
Swiss Prot
Q3KSS7
Host
Rabbit
Cross Reactivity
Human, Virus
Immunogen
151-250/605
Target
BRLF1
Clonality
Polyclonal
Conjugation
AbBy Fluor™ 488
Source
KLH conjugated synthetic peptide derived from human HHV4tp2 BRLF1
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
499nm/519nm
Concentration
1ug/ul
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx307117-01 20 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details abx307117-02 50 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details 
abx307117-03 100 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details abx307117-04 200 µg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details abx307117-05 1 mg
Squamous Cell Carcinoma Antigen Recognized By T-Cells 3 (SART3) Antibody (FITC)
Ask
View Details